Health services and systems: latest news

Health services and systems resources

Health services and systems features

Health services and systems in your own words

  • Going into hospital

    My experiences of hospitalisation are mixed. I’ve been admitted twice in the last six months, both times for a minor operation. However, following the excellent...

    From: In your own words

Health services and systems news from aidsmap

More news

Health services and systems news selected from other sources

  • Interview With Charles Gore, Medicines Patent Pool Executive Director

    Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going.

    23 hours ago | Intellectual Property Watch
  • A Farewell to Project Inform from HIV Research Advocate David Evans

    The HIV community was dealt a sad blow this week when it was announced that the iconic non-profit HIV treatment advocacy organization, Project Inform, will end its programs. Project Inform’s Director of Research Advocacy, David Evans, has been working with the organization in various capacities for the last 27 years. In this message shared with My Fabulous Disease, David reflects on Project Inform’s legacy and on the influence of its legendary founder, Martin Delaney. We must all honor this legacy by ensuring that HIV treatment advocacy remain at the forefront of our movement.

    18 March 2019 | My Fabulous Disease
  • Hepatitis C Treatment Market to Exceed US$ 71.13 Bn by the end of 2024

    The global hepatitis C treatment market was valued at US$ 23.9 Bn in 2015 and is estimated to be valued at US$ 26.6 Bn by 2016. The market is expected to reach a valuation of US$ 71.13 Bn by the end of 2024, reflecting a cumulative annual growth rate of 13.1% over the forecast period.

    04 March 2019 | Honest Businessman
  • A new way to pay for innovative drugs, provide universal access and not break the bank

    Louisiana, which has a severe hepatitis C problem, is on the cusp of proving to other states that drug companies can make the money they need, while every Medicaid recipient who needs a cure gets one. The state is now on a path to secure immediate treatment for all infected prisoners and people on Medicaid by buying a license from a drug company. It is a concept that can be applied to other ground breaking remedies.

    28 February 2019 | The Conversation
  • HIV Drug Prices Keep Rising. Why Is No One Talking About It?

    In order to adequately address the HIV epidemic in the United States, two advocates argue that the high cost of antiretroviral drugs must be addressed.

    30 January 2019 | The Body
  • Allowing Insurers to Dictate Therapies Harms People Living with HIV

    A new proposed rule by the Trump Administration could give insurance companies the power to restrict access to medications that people living with HIV need. Under the proposal, insurance companies could also require “prior authorization” and/or “step therapy,” which would force patients to use and fail cheaper therapies before getting access to more effective ones.

    29 January 2019 | BETA blog
  • Thailand: The long road to zero

    A Bangkok symposium on HIV/Aids looks at the progress being made to turn the disease from “epidemic” to “endemic”.

    25 January 2019 | The Nation
  • Trump Wants to Restrict Access to HIV Meds for People on Medicare

    In a move to cut Medicare costs, the proposed changes would also affect people with cancer, depression and schizophrenia.

    29 November 2018 | Poz
  • More than half of children living with HIV still without treatment in high burden, PEPFAR-supported southern African countries

    Data across 20 countries receiving PEPFAR support showed 56 percent of children living with HIV under the age of 15 — an estimated 750,000 children — are not receiving the life-saving treatment that also prevents transmission of the virus.

    18 May 2018 | Science Speaks
  • HIV response in Nigeria buckles under pressure of continued conflict with Boko Haram

    New comparison reveals significant drops in HIV service provision, as Nigeria’s Borno State feels the impact of years of armed conflict with Boko Haram.  

    05 May 2018 | AVERT
More news
Tell us why you visited aidsmap today
minimise

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?

close

Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email info@nam.org.uk.

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.